United States - English - NLM (National Library of Medicine)

ani pharmaceuticals, inc. - vancomycin hydrochloride (unii: 71wo621tjd) (vancomycin - unii:6q205eh1vu) - vancomycin 125 mg - vancocin is indicated for the treatment of clostridioides difficil e-associated diarrhea. vancocin is also used for the treatment of enterocolitis caused by staphylococcus aureus (including methicillin-resistant strains) in adult and pediatric patients less than 18 years of age. limitations of use to reduce the development of drug-resistant bacteria and maintain the effectiveness of vancocin and other antibacterial drugs, vancocin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. vancocin is contraindicated in patients with known hypersensitivity to vancomycin. risk summary systemic absorption of vancomycin is low following oral administration of vancocin; however, absorpt

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - vancomycin hydrochloride, quantity: 128 mg (equivalent: vancomycin, qty 125 mg) - capsule - excipient ingredients: iron oxide red; gelatin; indigo carmine; titanium dioxide; macrogol 6000; iron oxide yellow - this product accepted for registration as 'currently supplied' at the time of commencement of the act. revisions of product information was approved as specified in the letter of 13 august 1992 from dr alex proudfoot advising of approval for registration of the goods. indicated for the treatment of staphylococcal enterocolitis and antibiotic - associated pseudomembranous colitis produced by c. difficile.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - vancomycin hydrochloride, quantity: 256 mg (equivalent: vancomycin, qty 250 mg) - capsule - excipient ingredients: iron oxide black; titanium dioxide; indigo carmine; iron oxide red; gelatin; macrogol 6000 - this product accepted for registration as 'currently supplied' at the time of commencement of the act. revision of product information was approved as specified in the letter of 13 august 1992 from dr alex proudfoot advising of approval for registration of the goods. indicated for staphylococcal enterocolitis and antibiotic - associated pseudomembranous colitis produced by c. difficile.

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - vancomycin, quantity: 1 g (equivalent: vancomycin, qty 1 million iu) - injection, powder for - excipient ingredients: disodium edetate; sodium hydroxide; hydrochloric acid - indicated for potentially life-threatening infections which cannot be treated with another effective, less toxic antimicrobial drug, including the penicillins and cephalosporins. severe staphylococcal (including methicillin-resistant staphylococcal) infections in patients who cannot receive or who failed to respond to the penicillins and cephalosporins or who have infections with staphylococci that are resistant to other antibiotics. once sensitivity data are available, therapy should be adjusted accordingly. alone or in combination with an aminoglycoside for endocarditis caused by s. viridans or s. bovis. for endocarditis caused by enterococci (eg e faecalis), only in combination with an aminoglycoside. for the treatment of diphtheroid endocarditis. in combination with rifampin, an aminoglycoside or both in early-onset prosthetic valve endocarditis caused by s. epidermidis or diphtheroids. in other infections due to staphylococci including osteomyelitis, pneumonia, septicaemia, and soft tissue infections. wh

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - vancomycin, quantity: 500 mg (equivalent: vancomycin, qty 500000 iu) - injection, powder for - excipient ingredients: disodium edetate; hydrochloric acid; sodium hydroxide - indicated for potentially life-threatening infections which cannot be treated with another effective, less toxic antimicrobial drug, including the penicillins and cephalosporins. severe staphylococcal (including methicillin-resistant staphylococcal) infections in patients who cannot receive or who failed to respond to the penicillins and cephalosporins or who have infections with staphylococci that are resistant to other antibiotics. once sensitivity data are available, therapy should be adjusted accordingly. alone or in combination with an aminoglycoside for endocarditis caused by s. viridans or s. bovis. for endocarditis caused by enterococci (eg e faecalis), only in combination with an aminoglycoside. for the treatment of diphtheroid endocarditis. in combination with rifampin, an aminoglycoside or both in early-onset prosthetic valve endocarditis caused by s. epidermidis or diphtheroids. in other infections due to staphylococci including osteomyelitis, pneumonia, septicaemia, and soft tissue infections. wh

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - vancomycin -

Ireland - English - HPRA (Health Products Regulatory Authority)

flynn pharma limited - vancomycin - powder for concentrate for solution for infusion - 500 milligram(s) - glycopeptide antibacterials; vancomycin

Ireland - English - HPRA (Health Products Regulatory Authority)

flynn pharma limited - vancomycin - powder for concentrate for solution for infusion - 1 gram(s) - glycopeptide antibacterials; vancomycin

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

flynn pharma ltd - vancomycin hydrochloride - oral capsule - 125mg

Ireland - English - HPRA (Health Products Regulatory Authority)

flynn pharma limited - vancomycin hydrochloride - capsule, hard - 125 milligram(s) - glycopeptide antibacterials; vancomycin